FDC
|
FDC Last 5 Year Financial Ratios History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 18.75 | 11.70 | 12.82 | 17.85 | 14.03 |
CEPS(Rs) | 21.19 | 14.03 | 15.01 | 20.08 | 16.22 |
DPS(Rs) | - | - | - | - | 0.80 |
Book NAV/Share(Rs) | 128.81 | 119.47 | 115.92 | 102.73 | 90.51 |
Tax Rate(%) | 23.01 | 24.82 | 25.30 | 22.32 | 25.03 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 16.93 | 13.57 | 16.12 | 24.46 | 21.25 |
EBIT Margin(%) | 20.02 | 14.24 | 18.59 | 28.65 | 23.45 |
Pre Tax Margin(%) | 19.82 | 14.02 | 18.39 | 28.40 | 23.21 |
PAT Margin (%) | 15.26 | 10.54 | 13.74 | 22.06 | 17.40 |
Cash Profit Margin (%) | 17.25 | 12.66 | 16.11 | 24.83 | 20.12 |
Performance Ratios | |||||
ROA(%) | 9.39 | 6.23 | 7.59 | 11.85 | 10.43 |
ROE(%) | 14.96 | 9.84 | 11.71 | 18.36 | 16.03 |
ROCE(%) | 19.62 | 13.27 | 15.78 | 23.74 | 21.56 |
Asset Turnover(x) | 0.62 | 0.59 | 0.55 | 0.54 | 0.60 |
Sales/Fixed Asset(x) | 2.04 | 1.91 | 1.70 | 1.57 | 1.66 |
Working Capital/Sales(x) | 2.66 | 2.58 | 2.16 | 1.88 | 2.03 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.49 | 0.52 | 0.59 | 0.64 | 0.60 |
Receivable days | 21.91 | 20.32 | 22.35 | 31.31 | 27.96 |
Inventory Days | 65.48 | 62.83 | 60.27 | 56.79 | 50.80 |
Payable days | 101.39 | 87.78 | 73.73 | 86.01 | 83.79 |
Valuation Parameters | |||||
PER(x) | 22.65 | 21.94 | 20.04 | 16.00 | 13.97 |
PCE(x) | 20.04 | 18.29 | 17.11 | 14.23 | 12.08 |
Price/Book(x) | 3.30 | 2.15 | 2.22 | 2.78 | 2.17 |
Yield(%) | - | - | - | - | 0.41 |
EV/Net Sales(x) | 3.54 | 2.37 | 2.82 | 3.60 | 2.47 |
EV/Core EBITDA(x) | 15.64 | 14.07 | 13.06 | 11.13 | 9.19 |
EV/EBIT(x) | 17.20 | 16.16 | 14.72 | 12.27 | 10.28 |
EV/CE(x) | 3.28 | 2.13 | 2.19 | 2.75 | 2.14 |
M Cap / Sales | 3.56 | 2.39 | 2.84 | 3.62 | 2.49 |
Growth Ratio | |||||
Net Sales Growth(%) | 8.92 | 16.74 | 14.61 | -0.82 | 23.24 |
Core EBITDA Growth(%) | 46.32 | -8.78 | -23.50 | 19.14 | 31.83 |
EBIT Growth(%) | 52.83 | -10.46 | -25.23 | 20.96 | 35.83 |
PAT Growth(%) | 57.39 | -10.33 | -28.23 | 25.56 | 41.28 |
EPS Growth(%) | 60.30 | -8.77 | -28.19 | 27.23 | 44.12 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | - | - | - | - | - |
Current Ratio(x) | 2.22 | 1.98 | 2.05 | 2.17 | 2.21 |
Quick Ratio(x) | 1.59 | 1.53 | 1.61 | 1.82 | 1.83 |
Interest Cover(x) | 99.22 | 64.07 | 94.67 | 113.90 | 94.66 |
Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of FDC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FDC | ₹8,079.8 Cr | 0.4% | 3.5% | -2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,091.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,302.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹119,038.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹117,170.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,061.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
FDC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FDC | 0.4% |
3.5% |
-2% |
SENSEX | -1.1% |
1% |
3.4% |
You may also like the below Video Courses